First Wave BioPharma Inc (FWBI) concluded trading on 12/27/23 at a closing price of $5.53, with 26.31 million shares of worth about $145.48 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -82.16% during that period and on Wednesday the price saw a gain of about 49.86%. Currently the company’s 0.67M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 15 times over the past 12 months. They bought 873,725 shares in 7 of the transactions. In 8 selling transactions, insiders dumped 21,151 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
First Wave BioPharma Inc (NASDAQ: FWBI) started trading at $12.98, above $9.29 from concluding price of the previous day. Stock saw a price change of 55.77% in past 5 days and over the past one month there was a price change of 17.36%. Year-to-date (YTD), FWBI shares are showing a performance of -95.49% which decreased to -91.41% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.75 but also hit the highest price of $179.20 during that period. The average intraday trading volume for First Wave BioPharma Inc shares is 28.03K. The stock is currently trading 7.52% above its 20-day simple moving average (SMA20), while that difference is up 0.80% for SMA50 and it goes to -76.47% lower than SMA200.
Holding of mutual funds in the company is about — while other institutional holders and individual stake holders have control over — and — of the stake respectively.
The stock has a current market capitalization of $3.71M and its 3Y-monthly beta is at 1.44. It has posted earnings per share of -$163.48 in the same period. It has Quick Ratio of 1.60 while making debt-to-equity ratio of 0.07. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for FWBI, volatility over the week remained 44.14% while standing at 21.54% over the month.
Analysts are in expectations that First Wave BioPharma Inc (FWBI) stock would likely to be making an EPS of $Smith & Wesson Brands, Inc. in the current quarter, while forecast for next quarter EPS is $13.82 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $Northwest Bancshares, Inc. which is $First Guaranty Bancshares, Inc. at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $FWDI in the same quarter a year ago.
Analysts at 1 brokerage firms have issued recommendations for the First Wave BioPharma Inc (FWBI)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.00. Out of those 1 Wall Street analysts, 1 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
